StocksFin Logo
Abiomed, Inc. country of incorporation
|
|
Mr. Michael Minogue
|
2,003 employees
NASDAQ | Healthcare | Medical Devices
Maravai LifeSciences Holdings, Inc. country of incorporation
|
|
470 employees
NASDAQ | Healthcare | Biotechnology
Q223 reported Nov 3, 2022 Reporting Period
$265.92M 7.2% vs. Q222 Revenues Q223
81.62% -0.8% vs. Q222 Gross Profit Margin
39.91% 73.9% vs. Q222 Net Profit Margin
7.81M -87.1% vs. Q222 Free Cash Flow Q223
$2.34 87.2% vs. Q222 EPS Q223
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
Q322
Q322 reported Nov 4, 2022 Reporting Period
$191.26M -6.6% vs. Q321 Revenues Q322
80.04% -5.1% vs. Q321 Gross Profit Margin
23.25% -12.3% vs. Q321 Net Profit Margin
103.59M -2.1% vs. Q321 Free Cash Flow Q322
$0.34 -26.1% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
Q322
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
6.82
6.48
Current Ratio
7.93
7.22
Cash Ratio
1.36
5.34
Price to Book
7.24
6.67
Price to Sales
41.92
17.56
Price to Earnings
26.25
18.88